Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | corticotropin releasing hormone binding protein | No references | |
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Homo sapiens | K(lysine) acetyltransferase 2A | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | synuclein, alpha (non A4 component of amyloid precursor) | Starlite/ChEMBL | No references |
Homo sapiens | corticotropin releasing hormone receptor 2 | No references | |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | corticotropin releasing hormone receptor 2 | 438 aa | 383 aa | 26.1 % |
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | geminin | 0.0205 | 0.8199 | 1 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0051 | 0.1433 | 0.1747 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.2538 | 0.3096 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0977 | 0.0977 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0051 | 0.1433 | 0.5 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.017 | 0.6675 | 0.8141 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0051 | 0.1433 | 0.5 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.0047 | 0.1243 | 0.5 |
Brugia malayi | RNA binding protein | 0.0076 | 0.2538 | 0.2538 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2538 | 0.3096 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2538 | 0.3096 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.1818 | 0.1818 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.2538 | 0.2538 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0977 | 0.0977 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0977 | 0.1191 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.5528 | 0.5528 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.2538 | 0.2538 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0051 | 0.1433 | 0.5 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0047 | 0.1243 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0245 | 1 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.2538 | 0.3096 |
Plasmodium falciparum | histone acetyltransferase GCN5 | 0.0047 | 0.1243 | 0.5 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0175 | 0.6892 | 0.8405 |
Echinococcus multilocularis | geminin | 0.0205 | 0.8199 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2538 | 0.3096 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2538 | 0.3096 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.2538 | 0.2538 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0204 | 0.8182 | 0.9979 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.2538 | 0.2538 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0175 | 0.6892 | 0.6892 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2538 | 0.3096 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.5528 | 0.5528 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.8199 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0204 | 0.8182 | 0.9979 |
Loa Loa (eye worm) | acetyltransferase | 0.0175 | 0.6892 | 0.6892 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.8199 | 1 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0051 | 0.1433 | 0.5 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0175 | 0.6892 | 0.8405 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.1818 | 0.1818 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.5528 | 0.5528 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.2538 | 0.2538 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0051 | 0.1433 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | > 53 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS hits for small molecule agonists of the CRF-binding protein and CRF-R2 receptor complex. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (functional) | = 0.61 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS hits for small molecule antagonists of the CRF-binding protein and CRF-R2 receptor complex. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.7943 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398] | ChEMBL. | No reference |
Potency (functional) | 1 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 1.5849 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.5481 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 13.1154 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)] | ChEMBL. | No reference |
Potency (functional) | 32.6427 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143] | ChEMBL. | No reference |
Potency (functional) | 37.933 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 89.1251 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.